Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Ideaya Biosciences Inc’s stock clocked out at $30.41, up 2.81% from its previous closing price of $29.58. In other words, the price has increased by $2.81 from its previous closing price. On the day, 1.17 million shares were traded. IDYA stock price reached its highest trading level at $31.73 during the session, while it also had its lowest trading level at $29.68.
Ratios:
To gain a deeper understanding of IDYA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.93 and its Current Ratio is at 22.93. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2628390912 and an Enterprise Value of 1727158016. For the stock, the TTM Price-to-Sale (P/S) ratio is 670.51 while its Price-to-Book (P/B) ratio in mrq is 2.22. Its current Enterprise Value per Revenue stands at 440.377 whereas that against EBITDA is -7.769.
Stock Price History:
Over the past 52 weeks, IDYA has reached a high of $47.74, while it has fallen to a 52-week low of $27.52. The 50-Day Moving Average of the stock is -6.65%, while the 200-Day Moving Average is calculated to be -21.85%.
Shares Statistics:
It appears that IDYA traded 701.87K shares on average per day over the past three months and 752570 shares per day over the past ten days. A total of 84.48M shares are outstanding, with a floating share count of 76.56M. Insiders hold about 9.37% of the company’s shares, while institutions hold 92.04% stake in the company. Shares short for IDYA as of 1728950400 were 9607551 with a Short Ratio of 13.69, compared to 1726185600 on 11703657. Therefore, it implies a Short% of Shares Outstanding of 9607551 and a Short% of Float of 12.4.
